The main limitation of adverse drug reactions (ADRs) reporting, particularly by general practitioners (GP), to the regional pharmacovigilance centers is under-reporting. The Midi-Pyrénées Regional Pharmacovigilance Center (South western, France) sets up regular visits by a clinical research assistant (CRA) to GP in order to increase the number of ADR reports. The aim of this pilot study was to assess the effect of regular visits of a CRA in GPs offices on the rate of ADR reporting. After one year, CRA visits permit a two-fold increase in ADR reporting.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.therap.2016.09.004 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!